Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia. Issue 4 (4th March 2016)

• Record Type: Journal Article
• Authors: Sang, Wei; Wang, Ying; Zhang, Cong; Yan, Dongmei; Niu, Mingshan; Yang, Chun; Liu, Xia; Sun, Cai; Zhang, Zhe; Loughran, Thomas P.; Xu, Kailin
• Is Part Of: Clinical case reports. Volume 4:Issue 4(2016)
• Page Start: 390
• Page End: 395
• Publication Date: 2016-03-04
• Subjects: Allogeneic hematopoietic stem cell transplantation -- graft‐versus‐host disease -- Ph+ acute lymphoblastic leukemia -- T cells; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.438
• Languages: English
• ISSNs: 2050-0904

Abstract

Key Clinical Message: In this report, a case of relapsed Ph+ ALL was remedied by reinduction, and consolidation regimen of TKI and Flu+ Ara‐C+ IDA (FLAI) combination, followed by haploidentical SCT. Results suggest that FLAI together with TKI and subsequently with haploidentical SCT could be applied for relapsed Ph+ ALL. Abstract : In this report, a case of relapsed Ph+ ALL was remedied by reinduction, and consolidation regimen of TKI and Flu+ Ara‐C+ IDA (FLAI) combination, followed by haploidentical SCT. Results suggest that FLAI together with TKI and subsequently with haploidentical SCT could be applied for relapsed Ph+ ALL.